Entry |
|
Symbol |
PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta
|
Name |
(RefSeq) protein phosphatase 3 catalytic subunit beta
|
KO |
K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
Organism |
|
Pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04658 | Th1 and Th2 cell differentiation |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Network |
nt06160 Human T-cell leukemia virus 1 (HTLV-1) nt06161 Human immunodeficiency virus 1 (HIV-1) nt06164 Kaposi sarcoma-associated herpesvirus (KSHV) nt06165 Epstein-Barr virus (EBV) nt06167 Human cytomegalovirus (HCMV) nt06220 Calcium signaling (cancer) nt06528 Calcium signaling nt06537 TCR/BCR signaling |
Element |
N00147 | EGF-EGFR-PLCG-calcineurin signaling pathway |
N00401 | CXCR4-GNAQ-PLCB/G-calcineurin signaling pathway |
N00487 | BCR-PLCG-Calcineurin signaling pathway |
N01647 | Ca2+/CAM-CN signaling pathway |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
5532 (PPP3CB)
04310 Wnt signaling pathway
5532 (PPP3CB)
04370 VEGF signaling pathway
5532 (PPP3CB)
04020 Calcium signaling pathway
5532 (PPP3CB)
04022 cGMP-PKG signaling pathway
5532 (PPP3CB)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
5532 (PPP3CB)
04218 Cellular senescence
5532 (PPP3CB)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
5532 (PPP3CB)
04650 Natural killer cell mediated cytotoxicity
5532 (PPP3CB)
04660 T cell receptor signaling pathway
5532 (PPP3CB)
04658 Th1 and Th2 cell differentiation
5532 (PPP3CB)
04659 Th17 cell differentiation
5532 (PPP3CB)
04662 B cell receptor signaling pathway
5532 (PPP3CB)
09152 Endocrine system
04922 Glucagon signaling pathway
5532 (PPP3CB)
04921 Oxytocin signaling pathway
5532 (PPP3CB)
04924 Renin secretion
5532 (PPP3CB)
09156 Nervous system
04724 Glutamatergic synapse
5532 (PPP3CB)
04728 Dopaminergic synapse
5532 (PPP3CB)
04720 Long-term potentiation
5532 (PPP3CB)
09158 Development and regeneration
04360 Axon guidance
5532 (PPP3CB)
04380 Osteoclast differentiation
5532 (PPP3CB)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5532 (PPP3CB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5532 (PPP3CB)
05170 Human immunodeficiency virus 1 infection
5532 (PPP3CB)
05163 Human cytomegalovirus infection
5532 (PPP3CB)
05167 Kaposi sarcoma-associated herpesvirus infection
5532 (PPP3CB)
09171 Infectious disease: bacterial
05152 Tuberculosis
5532 (PPP3CB)
09164 Neurodegenerative disease
05010 Alzheimer disease
5532 (PPP3CB)
05014 Amyotrophic lateral sclerosis
5532 (PPP3CB)
05020 Prion disease
5532 (PPP3CB)
05022 Pathways of neurodegeneration - multiple diseases
5532 (PPP3CB)
09165 Substance dependence
05031 Amphetamine addiction
5532 (PPP3CB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5532 (PPP3CB)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:hsa01009]
5532 (PPP3CB)
Enzymes [BR:hsa01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
5532 (PPP3CB)
Protein phosphatases and associated proteins [BR:hsa01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
5532 (PPP3CB)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
Position |
10:complement(73436433..73496024)
|
AA seq |
524 aa
MAAPEPARAAPPPPPPPPPPPGADRVVKAVPFPPTHRLTSEEVFDLDGIPRVDVLKNHLV
KEGRVDEEIALRIINEGAAILRREKTMIEVEAPITVCGDIHGQFFDLMKLFEVGGSPANT
RYLFLGDYVDRGYFSIECVLYLWVLKILYPSTLFLLRGNHECRHLTEYFTFKQECKIKYS
ERVYEACMEAFDSLPLAALLNQQFLCVHGGLSPEIHTLDDIRRLDRFKEPPAFGPMCDLL
WSDPSEDFGNEKSQEHFSHNTVRGCSYFYNYPAVCEFLQNNNLLSIIRAHEAQDAGYRMY
RKSQTTGFPSLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFT
WSLPFVGEKVTEMLVNVLSICSDDELMTEGEDQFDGSAAARKEIIRNKIRAIGKMARVFS
VLREESESVLTLKGLTPTGMLPSGVLAGGRQTLQSATVEAIEAEKAIRGFSPPHRICSFE
EAKGLDRINERMPPRKDAVQQDGFNSLNTAHATENHGTGNHTAQ |
NT seq |
1575 nt +upstreamnt +downstreamnt
atggccgccccggagccggcccgggctgcaccgcccccacccccgcccccgccgccccct
cccggggctgaccgcgtcgtcaaagctgtccctttccccccaacacatcgcttgacatct
gaagaagtatttgatttggatgggatacccagggttgatgttctgaagaaccacttggtg
aaagaaggtcgagtagatgaagaaattgcgcttagaattatcaatgagggtgctgccatc
cttcggagagagaaaaccatgatagaagtagaagctccaatcacagtgtgtggtgacatc
catggccaattttttgatctgatgaaactttttgaagtaggaggatcacctgctaataca
cgatacctttttcttggcgattatgtggacagaggttattttagtatagagtgtgtctta
tatttatgggttctgaagattctatacccaagcacattatttcttctgagaggcaaccat
gaatgcagacaccttactgaatattttacctttaagcaggaatgtaaaattaagtattcg
gaaagagtctatgaagcttgtatggaagcttttgatagtttgcctcttgctgcactttta
aaccaacagtttctttgtgttcatggtggactttcaccagaaatacacacactggatgat
attaggagattagatagattcaaagagccacctgcatttggaccaatgtgtgacttgtta
tggtccgatccttctgaagattttggaaatgaaaaatcacaggaacattttagtcacaat
acagttcgaggatgttcttatttttataactatccagcagtgtgtgaatttttgcaaaac
aataatttgttatcgattattagagctcatgaagctcaagatgcaggctatagaatgtac
agaaaaagtcaaactacagggttcccttcattaataacaattttttcggcacctaattac
ttagatgtctacaataataaagctgctgtattaaagtatgaaaataatgtgatgaatatt
cgacagtttaactgttctccacatccttactggttgcctaattttatggatgtcttcacg
tggtctttaccgtttgttggagaaaaagtgacagaaatgttggtaaatgttctgagtatt
tgctctgatgatgaactaatgactgaaggtgaagaccagtttgatggttcagctgcagcc
cggaaagaaatcataagaaacaaaattcgagcaattggcaagatggcaagagtcttctct
gttctcagggaggagagtgaaagtgtgctgacactcaagggcctgactcccacagggatg
ttgcctagtggagtgttagctggaggacggcagaccctgcaaagtgccacagttgaggct
attgaggctgaaaaagcaatacgaggattctctccaccacatagaatctgcagttttgaa
gaggcaaagggtttggataggatcaatgagagaatgccacctcggaaagatgctgtacag
caagatggtttcaattctctgaacaccgcacatgccactgagaaccacgggacgggcaac
catactgcccagtga |